Conference abstract · 28 Aug 2020
Conference abstractPublished 16 Oct 2017
Hot-Melt Extrusion: A cost effective approach leading to enhancement of bioavailability and acceleration of drug product development process via turning poorly water soluble drugs into viable therapeutics
Egis Pharmaceuticals PLC, Hungary
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For orally administered drugs, water solubility and permeability are the rate-limiting factors to achieve their desired concentration in systemic circulation for the pharma¬cological response. Poor water solubility of new chemical entities belonging to Biopharmaceutical Classification System (BCS) class II and IV accounts for 40 to 70% incidence of delay or failure during the drug product development process. Therefore, turning poorly water soluble drugs into viable therapeutics is the recurring and most challenging aspect of drug product developmental process facing by formulation scientist. Hence, the poor bioavailability of the drugs has intensified demand for technologies and methods in the pharmaceutical industries to overcome their traits and meet the aforesaid challenges. Development of the formulations of BCS class II and IV drugs by converting the poorly water-soluble crystalline form into a more soluble amorphous form within the polymeric blends will enhance the solubility which in turn leads to the improved bioavailability. These formulations can be developed by adopting various solid dispersion technological approaches like Hot-Melt Extrusion (HME), kneading technique, co-precipitation, co-grinding, spray-drying, lyophilization, melt agglomeration process and supercritical fluid process. Among all these approaches, solid dispersion prepared by HME has gained popularity in the pharmaceutical industry as a means of improv¬ing the bioavailability of drugs due to its wide applications, simple pro¬cess and low cost. HME is an efficient technology for producing solid molecular dispersions with considerable advantages including the absence of solvents, few processing steps, and con¬tinuous operation over solvent-based processes such as spray drying and co-precipitation. Also, HME is one of the recommended processes by FDA to encourage move from batch-to-continuous manufacturing. Moreover, it is a value addition to intangible property of organization and can be used as non-infringing strategies for product developments.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Dec 2022
Bioavailability enhancement of poorly water-soluble drugs (BCS Class II and IV Drugs) using Hot-Melt Extrusion (HME): The cost-effective approach
Conference abstract · 7 May 2018
Hot-melt extrusion (HME) and its application for bioavailability improvement of poorly water soluble drugs
Short communication · 29 May 2025
Hot-Melt Extrusion: Enhancing Drug Solubility and Delivery
Conference abstract
Hot melt extrusion: A novel approach for the development of poorly soluble drugs
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectEnvironmental & Earth Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Devendra Ridhurkar”
